Abstract
Peptide-based molecular beacons are Förster resonance energy transfer-based target-activatable probes. They offer control of fluorescence emission in response to specific cancer targets and thus are useful tools for in vivo cancer imaging. With our increasing knowledge about human genome in health and disease, peptide-based “smart” probes are continually developed for in vivo optical imaging of specific molecular targets, biological pathways and cancer progression and diagnosis. A class of fluorescent photosensitizers further extends the application of peptide beacons to cancer therapeutics. This review highlights the applications of peptide beacons in cancer imaging, the simultaneous treatment and response monitoring and smart therapeutics with a focus on recent improvements in the design of these probes.
Similar content being viewed by others
References
Bremer C (2008) Optical Methods. Handb Exp Pharmacol 185(Pt 2):3–12
Bremer C, Tung CH, Weissleder R (2001) Optical methods. Nat Med 7(6):743–748
Bullok K, Piwnica-Worms D (2005) Synthesis and characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis. J Med Chem 48:5404–5407
Campo MA, Gabriel D, Kucera P, Gurny R, Lange N (2007) Polymeric photosensitizer prodrugs for photodynamic therapy. Photochem Photobiol 83:958–965
Carmel A, Zur M, Yaron A, Katchalski E (1973) Use of substrates with fluorescent donor and acceptor chromophores for the kinetic assay of hydrolases. FEBS Lett 30:11–14
Chance B (1998) Near-infrared images using continuous, phase-modulated, and pulsed light with quantitation of blood and blood oxygenation. Ann N Y Acad Sci 9(838):29–45
Chang E, Miller JS, Sun J, Yu WW, Colvin VL, Drezek R, West JL (2005) Protease-activated quantum dot probes. Biochem Biophys Res Commun 334:1317–1321
Chen J, Stefflova K, Niedre MJ, Wilson BC, Chance B, Glickson JD, Zheng G (2004) Protease-triggered photosensitizing beacon based on singlet oxygen quenching and activation. J Am Chem Soc 126:11450–11451
Chen Y, Gryshuk A, Achilefu S, Ohulchansky T, Potter W, Zhong T, Morgan J, Chance B, Prasad PN, Henderson BW, Oseroff A, Pandey RK (2005) A novel approach to a bifunctional photosensitizer for tumor imaging and phototherapy. Bioconjug Chem 16:1264–1274
Chen J, Jarvi M, Lo P, Stefflova K, Wilson BC, Zheng G (2007) Using the singlet oxygen scavenging property of carotenoid in photodynamic molecular beacons to minimize photodamage to non-targeted cells. Photochem Photobiol Sci 6:1311–1317
Chen J, Lovell JF, Lo P, Stefflova K, Niedre M, Wilson BC, Zheng G (2008) A tumor mRNA-triggered photodynamic molecular beacon based on oligonucleotide hairpin control of singlet oxygen production. Photochem Photobiol Sci 7:775–781
Chen J, Liu TWB, Lo P, Wilson BC, Zheng G (2009) "Zipper" molecular beacons: a generalized strategy to optimize the performance of activatable protease probes. Bioconjug Chem 20(10):1836–1842
Cicek M, Oursler MJ (2006) Breast cancer bone metastasis and current small therapeutics. Cancer Metastasis Rev 25:635–644
Dougherty TJ, Gomer CJ, Henderson BW, Jori G, Kessel D, Korbelik M, Moan J, Peng Q (1998) Photodynamic therapy. J Natl Cancer Inst 90(12):889–905
Forster T (1946) Energy migration and fluorescence. Naturwissenschaften 6:166–175
Fragioni JV (2003) In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 7(5):626–634
Funovics M, Weissleder R, Tung C (2003) Protease sensors for bioimaging. Anal Bioanal Chem 377:956–963
Gabriel D, Campo MA, Gurny R, Lange N (2007) Tailoring protease-sensitive photodynamic agents to specific disease-associated enzymes. Bioconjug Chem 18:1070–1077
Hsiao J, Law B, Weissleder R, Tung C (2006) In-vivo imaging of tumor associated urokinase-type plasminogen activator activity. J Biomed Opt 11:34013
Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y (2006) Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med 231:20–27
Jiang T, Olson ES, Nguyen QT, Roy M, Jennings PA, Tsien RY (2004) Tumor imaging by means of proteolytic activation of cell-penetrating peptides. Proc Natl Acad Sci USA 101:17867–17872
Josephson L, Kircher MF, Mahmood U, Tang Y, Weissleder R (2002) Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug Chem 13:554–560
Kelemen LE (2006) The role of folate receptor alpha in cancer development, progression and treatment: cause, consequence or innocent bystander? Int J Cancer 119:243–250
Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L (2003) A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 63:8122–8125
Krinick NL, Sun Y, Joyner D, Spikes JD, Straight RC, Kopecek J (1994) A polymeric drug delivery system for the simultaneous delivery of drugs activatable by enzymes and/or light. J Biomater Sci Polym Ed 5:303–324
Law B, Tung C (2009) Proteolysis: a biological process adapted in drug delivery, therapy, and imaging. Bioconjug Chem 20:1683–1695
Law B, Curino A, Bugge TH, Weissleder R, Tung C (2004) Design, synthesis, and characterization of urokinase plasminogen-activator-sensitive near-infrared reporter. Chem Biol 11:99–106
Law B, Weissleder R, Tung C (2007) Protease-sensitive fluorescent nanofibers. Bioconjug Chem 18:1701–1704
Lee S, Ryu JH, Park K, Lee A, Lee S, Youn I, Ahn C, Yoon SM, Myung S, Moon DH, Chen X, Choi K, Kwon IC, Kim K (2009) Polymeric nanoparticle-based activatable near-infrared nanosensor for protease determination in vivo. Nano Lett 9(12):4412–4416
Lo P, Chen J, Stefflova K, Warren MS, Navab R, Bandarchi B, Mullins S, Tsao M, Cheng JD, Zheng G (2009) Photodynamic molecular beacon triggered by fibroblast activation protein on cancer-associated fibroblasts for diagnosis and treatment of epithelial cancers. J Med Chem 52:358–368
Lobb RR, Auld DS (1979) Determination of enzyme mechanisms by radiationless energy transfer kinetics. Proc Natl Acad Sci USA 76(6):2684–2688
Lovell JF, Chen J, Jarvi MT, Cao W, Allen AD, Liu Y, Tidwell TT, Wilson BC, Zheng G (2009) FRET quenching of photosensitizer singlet oxygen generation. J Phys Chem B 113:3203–3211
Mahmood U, Weissleder R (2003) Near-infrared optical imaging of proteases in cancer. Mol Cancer Ther 2:489–496
Matayoshi ED, Wang GT, Krafft GA, Erickson J (1990) Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. Science 247:954–958
Maxwell D, Chang Q, Zhang X, Barnett EM, Piwnica-Worms D (2009) An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging. Bioconjug Chem 20:702–709
McIntyre JO, Fingleton B, Wells KS, Piston DW, Lynch CC, Gautam S, Matrisian LM (2004) Development of a novel fluorogenic proteolytic beacon for in vivo detection and imaging of tumour-associated matrix metalloproteinase-7 activity. Biochem J 377:617–628
Medintz IL, Clapp AR, Brunel FM, Tiefenbrunn T, Uyeda HT, Chang EL, Deschamps JR, Dawson PE, Mattoussi H (2006) Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot-peptide conjugates. Nat Mater 5(7):581–589
Moan J (1990) On the diffusion length of singlet oxygen in cells and tissues. J Photochem Photobiol B 6:344
Mohamed MM, Sloane BF (2006) Near-infrared optical imaging of proteases in cancer. Nat Rev Cancer 6:764–775
Ntziachristos V, Bremer C, Weissleder R (2003) Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 13:195–208
Pandey SK, Gryshuk AL, Sajjad M, Zheng X, Chen Y, Abouzeid MM, Morgan J, Charamisinau I, Nabi HA, Oseroff A, Pandey RK (2005) Multimodality agents for tumor imaging (PET, fluorescence) and photodynamic therapy. A possible “see and treat” approach. J Med Chem 48:6286–6295
Pandey AK, Sajjad M, Chen Y, Pandey A, Missert JR, Batt C, Yaho R, Nabi HA, Oseroff AR, Pandey RK (2009a) Compared to purpurinimides, the pyropheophorbide containing an iodobenzyl group showed enhanced PDT efficacy and tumor imaging (124I-PET) ability. J Med Chem 20:274–282
Pandey SK, Sajjad M, Chen Y, Zheng X, Yao R, Missert JR, Batt C, Bani HA, Oseroff AR, Pandey RK (2009b) Comparative positron-emission tomography (PET) imaging and phototherapeutic potential of 124I- labeled methyl- 3-(1′-iodobenzyloxyethyl)pyropheophorbide-a vs the corresponding glucose and galactose conjugates. J Med Chem 52:445–455
Pham W, Choi Y, Weissleder R, Tung CH (2004) Developing a peptide-based near-infrared molecular probe for protease sensing. Bioconjug Chem 15:1403–1407
Salazar MD, Ratnam M (2007) The folate receptor: what does it promise in tissue-targeted therapeutics? Cancer Metastasis Rev 26:141–152
Scherer RL, McIntyre JO, Matrisian LM (2008) Imaging matrix metalloproteinases in cancer. Cancer Metastasis Rev 27:679–690
Sega EI, Low PS (2008) Tumor detection using folate receptor-targeted imaging agents. Cancer Metastasis Rev 27:655–664
Stefflova K, Chen J, Marotta D, Li H, Zheng G (2006a) Photodynamic therapy agent with a built-in apoptosis sensor for evaluating its own therapeutic outcome in situ. J Med Chem 49:3850–3856
Stefflova K, Chen J, Li H, Zheng G (2006b) Targeted photodynamic therapy agent with a built-in apoptosis sensor for in vivo near-infrared imaging of tumor apoptosis triggered by its photosensitization in situ. Mol Imaging 5:520–532
Stefflova K, Chen J, Zheng G (2007) Killer beacons for combined cancer imaging and therapy. Curr Med Chem 14:2110–2125
Suzuki M, Husimi Y, Komatsu H, Suzuki K, Douglas KT (2008) Quantum dot FRET biosensors that respond to pH, to proteolytic or nucleolytic cleavage, to DNA synthesis, or to a multiplexing combination. J Am Chem Soc 130:5720–5725
Tung C (2004) Fluorescent peptide probes for in vivo diagnostic imaging. Biopolymers 76:391–403
Turk B (2006) Targeting proteases: successes, failures and future prospects. Nat Rev Drug Discov. 5:785–799
Weissleder R, Ntziachristos V (2003) Shedding light onto live molecular targets. Nat Med 9:123–128
Weissleder R, Tung CH, Mahmood U, Bogdanov A (1999) In vivo imaging of tumors with protease-activated near-infrared fluorescent probes. Nat Biotechnol 17:375–378
Wilson BC, Patterson MS (2008) The physics, biophysics and technology of photodynamic therapy. Phys Med Biol 53:R61–R109
Zheng G, Chen Y, Intes X, Chance B, Glickson J (2004) Contrast-enhanced near-infrared (NIR) optical imaging for subsurface cancer detection. J Porphyrins Phthalocyan 8:1105–1117
Zheng G, Chen J, Stefflova K, Jarvi M, Li H, Wilson BC (2007) Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation. Proc Natl Acad Sci USA 104:8989–8994
Zheng X, Morgan J, Pandey SK, Chen Y, Tracy E, Baumann H, Missert JR, Batt C, Jackson J, Bellnier DA, Henderson BW, Pandey RK (2009) Conjugation of 2-(1′-hexyloxyethyl)-2-devinylpyropheophorbide-a (HPPH) to carbohydrates changes its subcellular distribution and enhances photodynamic activity in vivo. J Med Chem 52:4306–4318
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Liu, T.W.B., Chen, J. & Zheng, G. Peptide-based molecular beacons for cancer imaging and therapy. Amino Acids 41, 1123–1134 (2011). https://doi.org/10.1007/s00726-010-0499-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00726-010-0499-1